Proposed Data Collections Submitted for Public Comment and Recommendations, 17251-17252 [05-6683]
Download as PDF
<![CDATA[
17251
Federal Register / Vol. 70, No. 64 / Tuesday, April 5, 2005 / Notices
ESTIMATE OF ANNUALIZED BURDEN TABLE
Number of
responses
per
respondent
Number of
respondents
Respondents
Average
burden
per response
(in hours)
Total response
burden hours
Survey respondents .........................................................................................
Virtual shopping respondents ..........................................................................
5000
1200
1
1
30/60
1
2500
1200
Total ..........................................................................................................
........................
........................
........................
3700
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 05–6682 Filed 4–4–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Data Collections Submitted
for Public Comment and
Recommendations
Proposed Project
The 317 Immunization Grant Program
Evaluation—New—National
Immunization Program (NIP), Centers
for Disease Control and Prevention
(CDC).
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–371–5983 or send
comments to Seleda Perryman, CDC
Assistant Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
comprehensive evaluation, a Grantee
Immunization Survey of 50 state and 6
urban project 317 Immunization
Program grantees will be conducted.
The program will evaluate current
operations and performance;
recommend processes to improve
efficiency, cost-effectiveness, and
accountability; and provide direction for
future funding cycles. Data will not be
collected from the four territories/
commonwealths and four freely
associated states because of their unique
socioeconomic, political and cultural
environments.
The Grantee Immunization Survey
will: (1) Provide information on the
resources and management activities of
the 317 Grant Program; (2) provide
information that will enable the 317
Grant Program to monitor program
operations and progress; and (3) provide
a mechanism for systematic collection
of robust program and cost data to
monitor program operations and
progress toward goals.
The 63 item Grantee Immunization
Survey will be completed on-line via a
password protected Web site by the
Immunization Program Manager and
other selected immunization program
staff as needed. The results will be used
to enhance the overall efficiency and
efficacy of the 317 Program thus
enhancing vaccine assurance and
delivery.
Collection of the information for this
study is a one-time effort. There are no
direct costs to respondents other than
their time to complete and return the
questionnaire.
Background and Brief Description:
The 317 Immunization Grant Program
is the primary vehicle through which
CDC’s NIP provides vaccine
infrastructure. It has been in existence
since its Congressional enactment in
1963 and provides annual grants to 50
states, six urban areas, four territories/
commonwealths and four freely
associated states for both vaccine
assurance and vaccine delivery. The 317
Grant Program provides recipients with
infrastructure support for diverse
program activities including
surveillance, immunization registries,
training, education, public information
and outreach, quality assurance of
providers, vaccine management and
purchase of vaccines for adults and
children who do not qualify for the
Vaccine for Children program.
In response to the Program
Assessment Rating Tool (PART) review
and the Office of Management and
Budget’s (OMB) recommendation for a
[60Day–05BR]
ESTIMATE OF ANNUALIZED BURDEN TABLE
Respondents
Number of
respondents
Number
responses
per respondent
Average
burden per
response
(in hours)
Total
response
burden
(in hours)
317—Immunization Grant Program Grantees .................................................
56
1
1
56
VerDate jul<14>2003
19:48 Apr 04, 2005
Jkt 205001
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
E:\FR\FM\05APN1.SGM
05APN1
17252
Federal Register / Vol. 70, No. 64 / Tuesday, April 5, 2005 / Notices
Dated: March 24, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 05–6683 Filed 4–4–05; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
Advisory Committee on
Interdisciplinary, Community-Based
Linkages; Notice of Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Centers for Disease Control and
Prevention
Health Resources and Services
Administration; CDC/HRSA Advisory
Committee on HIV and STD Prevention
and Treatment
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) and the
Health Resources and Services
Administration (HRSA) announce the
following committee meeting.
Name: CDC/HRSA Advisory Committee on
HIV and STD Prevention and Treatment.
Times and Dates: 8 a.m.–5 p.m., May 11,
2005. 8 a.m.–12 p.m., May 12, 2005.
Place: OMNI Hotel at CNN Center, 100
CNN Center, Atlanta, Georgia 30309.
Telephone: 404– 659–0000.
Status: Open to the public, limited only by
the space available. The meeting room will
accommodate approximately 100 people.
Purpose: This Committee is charged with
advising the Secretary, the Director, CDC,
and the Administrator, HRSA, regarding
activities related to prevention and control of
HIV/AIDS and other STDs, the support of
health care services to persons living with
HIV/AIDS, and education of health
professionals and the public about HIV/AIDS
and other STDs.
Matters to be Discussed: Agenda items
include issues pertaining to (1) HIV and STD
Disparities among African Americans, (2)
Routine HIV Testing in Health care settings
and (3) Ryan White CARE Act.
Agenda items are subject to change as
priorities dictate.
For Further Information Contact: Paulette
Ford-Knights, Public Health Analyst,
National Center for HIV, STD, and TB
Prevention, 1600 Clifton Road, NE., Mailstop
E–07, Atlanta, Georgia 30333. Telephone
404/639–8008, fax 404/639–3125, e-mail
pbf7@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: March 29, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–6681 Filed 4–4–05; 8:45 am]
BILLING CODE 4163–18–P
VerDate jul<14>2003
19:48 Apr 04, 2005
Jkt 205001
Health Resources and Services
Administration
Name: Advisory Committee on
Interdisciplinary, Community-Based
Linkages.
Dates and Times: May 1, 2005, 5 p.m.–9
p.m.; May 2, 2005, 8:30 a.m.–5 p.m.; May 3,
2005, 8:30 a.m.–2 p.m.
Place: The DoubleTree Hotel, 1750
Rockville Pike, Rockville, MD 20852.
Status: The meeting will be open to the
public.
Agenda: Agenda items will include, but
not be limited to: Welcome; plenary session
on Allied Health issues as they relate to the
grant programs under the purview of the
Committee with presentations by constituent
groups, field experts, committee members,
and speakers representing the Health
Resources and Services Administration,
Bureau of Health Professions, Division of
State, Community and Public Health
programs that incorporate allied health
disciplines. The following topics will be
addressed at the meeting: What are effective
allied health interdisciplinary training
programs, and how are they achieved; and
are allied health interdisciplinary training
programs meeting the needs of employers,
and what do those employers seek in allied
health professionals.
Proposed agenda items are subject to
change as priorities dictate.
Public Comments: Public comment will be
permitted at the end of the Committee
meeting on May 2, 2005, and before lunch on
May 3, 2005. Oral presentations will be
limited to 5 minutes per public speaker.
Persons interested in providing an oral
presentation should submit a written request,
with a copy of their presentation to: Ann
Bell, Public Health Fellow, Division of State,
Community and Public Health, Bureau of
Health Professions, Health Resources and
Services Administration, Room 8A–09, 5600
Fishers Lane, Rockville, MD 20857,
Telephone (301) 443–0582.
Requests should contain the name,
address, telephone number, and any business
or professional affiliation of the person
desiring to make an oral presentation. Groups
having similar interests are requested to
combine their comments and present them
through a single representative. The Division
of State, Community and Public Health will
notify each presenter by mail or telephone of
their assigned presentation time.
Persons who do not file a request in
advance for a presentation, but wish to make
an oral statement may register to do so at the
DoubleTree Hotel, Rockville, MD, on May 2,
2005. These persons will be allocated time as
the Committee meeting agenda permits.
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
For Further Information Contact: Anyone
requiring information regarding the
Committee should contact Ann Bell, Division
of State, Community and Public Health,
Bureau of Health Professions, Health
Resources and Services Administration,
Room 8A–09, 5600 Fishers Lane, Rockville,
MD 20857, Telephone (301) 443–0582.
Dated: March 30, 2005.
Tina M. Cheatham,
Director, Division of Policy Review and
Coordination.
[FR Doc. 05–6704 Filed 4–4–05; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Office for Women’s Services; Notice of
a Meeting
Pursuant to Public Law 92–463,
notice is hereby given of a meeting of
the Substance Abuse Mental Health
Services Administration (SAMHSA)
Advisory Committee for Women’s
Services to be held in April 2005.
The SAMHSA Advisory Committee
for Women’s Services’ meeting will be
open and will include presentations and
discussions on activities involving
women as they relate to mental health
and data, children, family therapy,
trauma, obesity and treatment. Also,
there will be updates on SAMHSA’s
budget and legislation programs.
Public attendance and public
comments are welcome. Please
communicate with the individual listed
below to make arrangements to
comment or to request special
accommodations for persons with
disabilities.
Substantive program information and
a roster of Committee members may be
obtained by accessing the SAMHSA
Advisory Councils’ Web site (https://
www.samhsa.gov) as soon as possible
after the meeting or by communicating
with the contact whose name and
telephone number are listed below. The
transcript for the session will also be
available on the SAMHSA Advisory
Council Web site as soon as possible
after the meeting.
Committee Name: SAMHSA Advisory
Committee for Women’s Services.
Meeting Date/Time: Open—Monday,
April 18, 2005; 9 a.m.–5 p.m. Open—
Tuesday, April 19, 2005; 9 a.m.–12
noon.
Place: 1 Choke Cherry Road, Sugarloaf
Room, Rockville, MD 20857.
For Further Information Contact:
Carol Watkins, Executive Secretary, 1
Choke Cherry Road, Room 8–1002,
E:\FR\FM\05APN1.SGM
05APN1
]]>Agencies
[Federal Register Volume 70, Number 64 (Tuesday, April 5, 2005)]
[Notices]
[Pages 17251-17252]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-6683]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-05BR]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-371-5983 or
send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
The 317 Immunization Grant Program Evaluation--New--National
Immunization Program (NIP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description:
The 317 Immunization Grant Program is the primary vehicle through
which CDC's NIP provides vaccine infrastructure. It has been in
existence since its Congressional enactment in 1963 and provides annual
grants to 50 states, six urban areas, four territories/commonwealths
and four freely associated states for both vaccine assurance and
vaccine delivery. The 317 Grant Program provides recipients with
infrastructure support for diverse program activities including
surveillance, immunization registries, training, education, public
information and outreach, quality assurance of providers, vaccine
management and purchase of vaccines for adults and children who do not
qualify for the Vaccine for Children program.
In response to the Program Assessment Rating Tool (PART) review and
the Office of Management and Budget's (OMB) recommendation for a
comprehensive evaluation, a Grantee Immunization Survey of 50 state and
6 urban project 317 Immunization Program grantees will be conducted.
The program will evaluate current operations and performance; recommend
processes to improve efficiency, cost-effectiveness, and
accountability; and provide direction for future funding cycles. Data
will not be collected from the four territories/commonwealths and four
freely associated states because of their unique socioeconomic,
political and cultural environments.
The Grantee Immunization Survey will: (1) Provide information on
the resources and management activities of the 317 Grant Program; (2)
provide information that will enable the 317 Grant Program to monitor
program operations and progress; and (3) provide a mechanism for
systematic collection of robust program and cost data to monitor
program operations and progress toward goals.
The 63 item Grantee Immunization Survey will be completed on-line
via a password protected Web site by the Immunization Program Manager
and other selected immunization program staff as needed. The results
will be used to enhance the overall efficiency and efficacy of the 317
Program thus enhancing vaccine assurance and delivery.
Collection of the information for this study is a one-time effort.
There are no direct costs to respondents other than their time to
complete and return the questionnaire.
Estimate of Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Number Average burden Total response
Respondents Number of responses per per response burden (in
respondents respondent (in hours) hours)
----------------------------------------------------------------------------------------------------------------
317--Immunization Grant Program Grantees.... 56 1 1 56
----------------------------------------------------------------------------------------------------------------
[[Page 17252]]
Dated: March 24, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 05-6683 Filed 4-4-05; 8:45 am]
BILLING CODE 4163-18-P
